evaluate the digital health company amwell on wegovy / semaglutide FDA Approval: CV Risk and Weight Management in Obesity FDA approves weight-loss drug Wegovy

Move your body daily

Use the reconstitution calculator to double-check your math

We use innovative technologies such as Miha Bodytec and Emsculpt NEO to amplify your weight loss with muscle gain

About 35% of non-diabetic patients and 51% of diabetic patients reinitiate GLP-1 therapy within a year of discontinuation

Lifestyle modifications remain fundamental to managing both diabetes and blood pressure: Dietary changes , including reducing salt intake to less than 6g per day and following a balanced diet rich in fruits, vegetables, and whole grains Regular physical activity , aiming for at least 150 minutes of moderate-intensity exercise per week [14] Weight management , which may be supported by the appetite-suppressing effects of Rybelsus Limiting alcohol consumption to no more than 14 units per week, spread over at least 3 days [15] Smoking cessation , which significantly reduces cardiovascular risk For patients already taking antihypertensive medications , any dose adjustments should only be made under medical supervision